🇺🇸 FDA
Patent

US 10329283

G protein-coupled receptor kinase inhibitors and methods for use of the same

granted A61PA61P9/00A61P9/12

Quick answer

US patent 10329283 (G protein-coupled receptor kinase inhibitors and methods for use of the same) held by THE REGENTS OF THE UNIVERSITY OF MICHIGAN expires Mon Jun 20 2039 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
THE REGENTS OF THE UNIVERSITY OF MICHIGAN
Grant date
Tue Jun 25 2019 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jun 20 2039 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
20
CPC classes
A61P, A61P9/00, A61P9/12